Sun Pharma Inks Pact to Develop Nervous System Drugs

New Delhi: Sun Pharma has entered into an agreement with Israel's Weizmann Institute of Science and Spain's Health Research Institute of Santiago de Compostela to develop products for treating neurological diseases like brain stroke and glioblastoma, a lethal brain cancer. Scientists at Weizmann Institute have developed a recombinant enzyme currently undergoing animal studies for indications of brain stroke and glioblastoma. Furthe...